Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes

J Exp Med. 2023 Jun 5;220(6):e20220525. doi: 10.1084/jem.20220525. Epub 2023 Mar 28.

Abstract

Clodronate liposomes (Clo-Lip) have been widely used to deplete mononuclear phagocytes (MoPh) to study the function of these cells in vivo. Here, we revisited the effects of Clo-Lip together with genetic models of MoPh deficiency, revealing that Clo-Lip exert their anti-inflammatory effects independent of MoPh. Notably, not only MoPh but also polymorphonuclear neutrophils (PMN) ingested Clo-Lip in vivo, which resulted in their functional arrest. Adoptive transfer of PMN, but not of MoPh, reversed the anti-inflammatory effects of Clo-Lip treatment, indicating that stunning of PMN rather than depletion of MoPh accounts for the anti-inflammatory effects of Clo-Lip in vivo. Our data highlight the need for a critical revision of the current literature on the role of MoPh in inflammation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Clodronic Acid* / pharmacology
  • Humans
  • Inflammation
  • Liposomes*
  • Neutrophils

Substances

  • Liposomes
  • Clodronic Acid
  • Anti-Inflammatory Agents